Drug Shortage Report for ACT NABILONE
| Report ID | 112394 |
| Drug Identification Number | 02393581 |
| Brand name | ACT NABILONE |
| Common or Proper name | NABILONE 0.5MG CAP |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NABILONE |
| Strength(s) | 0.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A04AD |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-15 |
| Estimated end date | Unknown |
| Actual end date | 2020-08-21 |
| Shortage status | Resolved |
| Updated date | 2021-09-23 |
| Company comments | Item is discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-04-16 | English | Compare |
| v2 | 2020-04-16 | French | Compare |
| v3 | 2020-08-20 | English | Compare |
| v4 | 2020-08-20 | French | Compare |
| v5 | 2021-09-23 | English | Compare |
| v6 | 2021-09-23 | French | Compare |
Showing 1 to 6 of 6